SENS Foundation was founded to develop, promote and ensure widespread access to regenerative medicine solutions to the disabilities and diseases of aging. We shall be focusing on the Strategies for Engineered Negligible Senescence (SENS) identified by our Chief Science Officer, Dr Aubrey de Grey, and combining direct research efforts with education, affiliation and outreach programs. You can find more about us, our mission and our history by following the links in the menu above.
SENS Foundation is pleased to announce an initiative by the Immortality Institute, funding us in our fight against aging. The Institute will match every contribution up to $8,000 for the study of laser ablation of lipofuscin - research that will be conducted by Nason Schooler at the SENS Foundation Research Center. For more information, and to donate to this exciting new project, please visit the Institute's 'Laser Research Grant' page.
Two of our founders, Chief Executive Officer Mike Kope and Dr de Grey, have written open letters to introduce you to our organization and its work. We hope that you will share the enthusiasm and confidence which they express, and support us as we deliver real progress in the engineering of comprehensive regenerative therapies.
